NP / PA
Marshall Urgent Care
Marshall Urgent Care was paid $953K by Medicaid between Jan 2018 and Dec 2024, across 44 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 50% of everything it billed.
33Billing provider infoMARSHALL URGENT CARE
HOLLY SPRINGS, MS 38635
HOLLY SPRINGS, MS 38635
33aNPI1588103246assigned 02/14/2017
33bProvider typeFamily Nurse Practitioner
28Total paid$953K
24GClaims35,782
24DCodes billed44
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Mississippi
Rank by total paid#8 of 206
Median peer was paid$22K
This provider vs. median44×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,648 | $236K | |
| 2019 | 5,465 | $168K | |
| 2020 | 2,712 | $71K | |
| 2021 | 5,727 | $153K | |
| 2022 | 6,127 | $132K | |
| 2023 | 4,611 | $130K | |
| 2024incomplete | 1,492 | $63K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 50% | 7,646 | 6,128 | $477K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 3,889 | 3,146 | $171K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 7.6% | 1,162 | 1,024 | $72K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.1% | 2,353 | 2,022 | $49K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.5% | 4,674 | 2,801 | $43K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4.2% | 3,729 | 3,124 | $40K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.5% | 919 | 807 | $33K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 3.4% | 1,233 | 1,083 | $32K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 550 | 471 | $9K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 57 | 57 | $5K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 35 | 29 | $3K |
| 87428 | <1% | 70 | 62 | $3K |
32 more codes
| 99051 | <1% | 187 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 842 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 953 | $1K |
| 81003 | <1% | 795 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 92 | $959.22 |
| 94375 | <1% | 53 | $929.88 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 16 | $847.59 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 81 | $719.25 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 616 | $702.67 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,507 | $634.41 |
| 94690 | <1% | 33 | $629.50 | |
| 92551 | <1% | 97 | $564.66 | |
| 87807 | <1% | 54 | $547.67 | |
| 94200 | <1% | 51 | $480.61 | |
| 0001A | <1% | 15 | $434.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 788 | $397.14 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 43 | $288.71 |
| 96127 | <1% | 90 | $256.75 | |
| 82947 | <1% | 72 | $153.48 | |
| 85018 | <1% | 108 | $152.09 | |
| 99173 | <1% | 85 | $131.97 | |
| 93000 | <1% | 16 | $126.81 | |
| 86308 | <1% | 27 | $115.90 | |
| 90686 | <1% | 14 | $83.93 | |
| 96160 | <1% | 15 | $29.07 | |
| A4208 | Syringe with needle, sterile 3 cc, each | <1% | 2,292 | $14.02 |
| 94760 | <1% | 116 | $10.25 | |
| J0945 | Injection, brompheniramine maleate, per 10 mg | <1% | 29 | $0.80 |
| A4206 | Syringe with needle, sterile, 1 cc or less, each | 0% | 18 | $0.00 |
| 91300 | 0% | 19 | $0.00 | |
| 36416 | 0% | 134 | $0.00 | |
| J1094 | Injection, dexamethasone acetate, 1 mg | 0% | 207 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJOYNER, CHRISTINA (OWNER/ADMINISTRATOR)